Trial Profile
Effect of intravitreal bevacizumab on clinically significant macular edema
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 01 Nov 2007 Staus change from recruiting to completed
- 19 Dec 2006 New trial record.